A revolutionary stem cell therapy has helped Amanda Smith ditch insulin injections for good, offering new hope to diabetics ...

The promise of stem cell therapy is powerful. Scientists can draw versatile cells from the human body and deliver them to ...

US drugmaker Vertex Pharmaceuticals has announced simultaneous presentation and publication of updated data from the Phase ...

The global cell therapy technologies market is set to witness a growth rate of 12% in the next 5 years. Rising prevalence of ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

With gene therapy in the works, clinical trials for sickle cell disease still lack Black American participants.

Most gene therapies being studied for eye diseases are in earlier phases of development, and a third of the gene therapies ...

Sana is Incorporating the Tested Immune Evasion Technology to Develop SC451, a HIP-modified, Stem Cell-Derived Therapy as a One-Time Treatment for Patients with Type 1 Diabetes, with a Goal of Normal ...

People living with Sickle Cell Disease (SCD) in Nigeria have lamented that the high cost of medication and poor access to comprehensive care are weighing heavily on them and their families.

The department has pledged it will meet an end-of-the-year deadline early for halting spinal cord injury research that used ...

Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...